Chemed Corp Stock News

Juniper's (JNPR) first-quarter 2020 performance is likely to have benefited from changes to its go-to-market structure to better align sales strategies with each of the core customer verticals.

Headwinds in the Optical Communications and Display Technologies business segments are likely to get reflected in Corning's (GLW) first-quarter 2020 results.

Headwinds in the Optical Communications and Display Technologies business segments are likely to get reflected in Corning's (GLW) first-quarter 2020 results.

The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group

The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group

Amid the coronavirus impact on sales, Edwards Lifesciences (EW) witnesses growth in TAVR procedures led by strong therapy adoption across all geographies, particularly in the United States.

Amid the coronavirus impact on sales, Edwards Lifesciences (EW) witnesses growth in TAVR procedures led by strong therapy adoption across all geographies, particularly in the United States.

Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1

ABIOMED's (ABMD) fiscal fourth-quarter performance is likely to reflect growth in Impella product line.

ABIOMED's (ABMD) fiscal fourth-quarter performance is likely to reflect growth in Impella product line.

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

Cabot Wealth Management Inc. reduced its stake in Chemed Co. (NYSE:CHE) by 1.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The in

News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.

The first-quarter 2020 earnings season has been set in motion.